85 research outputs found

    Etude de l’effet du kaki sur les caractéristiques organoleptiques du yaourt

    No full text
    L'objectif de ce projet est de formulé un nouveau produit laitier fonctionnel dit yaourt brassé qui incorpore à la fois des morceaux de kaki solides et la poudre de Diospyros kaki. Les principaux résultats de cette étude indiquent que le kaki est particulièrement riche en polyphénols et en flavonoïdes avec l'extrait éthanoïque présentant les concentrations les plus élevées de ces composés (170,909 ± 0,091 mg EAG/g ms et 30.80± 0,003 mg EQ/g ms, respectivement), aussi montrent que la poudre de fruit étudier est riche en eau et en sucre avec des pourcentages : 77,8±0,29% et 22,246±1,89(g/L), 8,087±0.07(g/L) et 13,73±0,12(g/L). Respectivement. L'analyse sensorielle réalisée a été appréciée selon cinq critères à savoir : la texture, goût, odeur et la couleur. L'évaluation de ces paramètres a été réalisée avec trois pots de 100 ml et un témoin : T5, T10, T15 et T0 qui est le témoin. Les résultats de l'analyse indiquent que le yaourt a 15g de mélange ajouté T15 a présenté un score très élevé par rapport a leur texture, gout, odeur et couleur. Cependant, la tendance s'inverse pour l'acidité en ce qui concerne la coagulation du lait utilisé

    Cardiologie [Cardiology]

    No full text
    The therapeutic acquisition to be retained for 2004 are: 1. The elderly patients with heart failure also should receive beta blocker treatment. The correction of anaemia, aggravating factor in heart failure, improves symptoms and survival of the patient. 2. It remains to prove that the treatment of sleep apnea, which seems to be an additional factor for mortality in cardiovascular diseases, is able to reduce the risk. 3. The interventions in the endocanabinoïd system which regulates weight and metabolic processes might be a promising new therapeutic acquisition. 4. Prevention of coronary disease with lipid lowering drugs is still a major topic, and the trend goes the lower the better. The problems observed with Rofecoxybe and other drug interactions reminds us to be conscious when prescribing multiple drugs. 5. The implantable defibrillator seems to be a life insurance in the event of ventricular fibrillation. However, it is not so easy to identify the patient who might really benefit

    Uptake of telehealth implementation for COPD patients in a high-poverty, inner-city environment: A survey

    No full text
    This study aimed to investigate computer and internet access and education attained in patients with chronic obstructive pulmonary disease (COPD) as potential barriers to implementation of telemedicine. We prospectively assessed 98 patients admitted with an acute exacerbation of COPD (mean age: 70.5 ± 9.3 years; force expired volume in the first second: 0.75 ± 0.39 L; 59% male) recording educational level attained and home computer and internet access. Hospital readmission surveillance occurred up to 2.7 (2.6-2.8) years following the index hospital admission. Only 16% of patients had a computer and only 14% had internet access; this group were younger and more educated than those without a computer. There was no difference in hospital readmissions over 2 years between those with and without access to a computer or internet. Only 12% of the whole cohort were educated to a school leaving age of 16 years and this group were more likely to be still working. School leaving age was directly associated with fewer hospital readmissions ( r = 0.251, p = 0.031). In conclusion, these data highlight the current challenges to the widespread implementation of telehealth in COPD patients as there is limited availability of computer and internet access with such patients demonstrating a lower level of education achievement

    Effect of postoperative physical training on activity after curative surgery for non-small cell lung cancer:a multicentre randomised controlled trial

    No full text
    Objective: To evaluate the effect of a combined hospital plus home exercise programme following curative surgery for non-small cell lung cancer (NSCLC).Design: Randomised controlled trial.Setting: Teaching hospital.Participants: One hundred and thirty-one subjects with NSCLC admitted for curative surgery.Interventions: Participants were randomised to usual care or a hospital plus home exercise programmeOutcomes: The primary outcome was the between-group difference in physical activity 4 weeks after surgery. Secondary outcomes were the difference in quadriceps strength, exercise tolerance and quality of life [Short Form-36 (SF-36) and European Organisation for Research and Treatment of Cancer (EORTC) QLQ-LC 13] from pre-operatively (baseline) to 4 weeks after surgery.Results: The participants (n = 131) had a mean age of 68 [standard deviation (SD) 11] years and mean forced expiratory volume in 1 second of 2.4 (SD 1.1)1. There were no significant differences in physical activity between the groups 4 weeks after surgery [mean difference adjusted for baseline 12 minutes/day, 95% confidence interval (CI) - 20.2 to 44.1. In addition, there were no significant differences in total SF-36 or EORTC QLQ-LC13 scores from baseline to 4 weeks after surgery. Both groups had recovered their pre-operative walking distance 4 weeks after surgery, and there were no differences between the groups (mean difference in Incremental Shuttle Walk Test from baseline to 4 weeks after surgery (-26 m, 95% CI -94.2 to 42.3).Conclusions: A hospital plus home exercise programme showed little benefit in unselected patients with NSCLC following surgery. Regardless of group allocation, the patients had recovered their pre-operative exercise tolerance levels by 4 weeks after surgery.</p
    corecore